Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

2nd IFOM-IEO Campus Meeting on Cancer - New therapeutic anti-cancer strategies: shortening telomeres

08.05.2006


Without the enzyme that “regenerates” telomeres (the ends of DNA), stem cells lose functionality and the organism rapidly ages, while it acquires cancer resistance. The finding, which has significant implications in cancer and aging research, was presented yesterday at the 2nd IFOM-IEO Campus Meeting on Cancer (May 5th – 8th, IFOM-IEO Campus, Milan, Italy) by Marìa A. Blasco, of the Spanish National Cancer Center (CNIO) in Madrid (Spain).



Our cells’ DNA has a sort of “tail”: the telomeres. Every time our cells divide, telomeres get shorter and shorter. This progressive telomere shortening is compensated by the action of a specific enzyme, called “telomerase”, which is able to regenerate the tails; but in our cells there is not enough telomerase to keep telomeres at a constant length during our lifetime. And when telomeres get too short, cells stop replicating. Scientists have long hypothesized (and partially proved, with several experiments) that telomere shortening is correlated, on the one hand, to the general aging of the body (when many cells in a tissue stop replicating, the tissue becomes unable to regenerate itself and gets “old”) and, on the other hand, to cancer (tumour cells replicate much more than normal cells, therefore they need some mechanism to counteract natural telomere shortening).

To make the picture even more complicated, stem cells (the other big “stars” of modern biology research) might be the only cells that are able to produce the enzyme telomerase. Intuitively this makes sense, since stem cells are the “mother cells” of all cells, and they are necessary to the body to regenerate tissues and organs during lifetime. But, what is the role of telomerase in stem cells? And what could happen if the enzyme is absent? To answer these questions, Blasco and colleagues set up a series of experiments in mice. And they found that the lack of telomerase causes a severe defect in the fundamental functions of stem cells. “In particular – Blasco said – we have been looking at skin stem cells. And we observed that, in genetically modified mice that did not express telomerase, stem cells lost their functionality and became unable to regenerate the damaged epithelial tissue. On the whole, these mice aged more rapidly than normal mice. But, there was a very interesting side effect: without telomerase, mice showed a marked cancer resistance.” Further experiments on telomeres structure showed that every time the shortening process is altered, the result is either “early aging and cancer resistance” (if shortening is boosted), or “aging inhibition and more cancer occurrence” (if shortening is reduced).


“In our lab – Blasco added – we do basic research, but our results provide fundamental knowledge to those who work on the development of new therapeutic tools. In this very moment, preclinical trials are being carried out on drugs that are able to boost the action of telomerase. The potential anti-aging effect of these drugs might prove useful in the treatment of diseases such as AIDS, where tissues age rapidly. In tumours, it is necessary to implement the opposite strategy: there are drugs, now in clinical trials, that inhibit telomerase action and increase telomeres shortening.” In the light of the new finding, such therapy might prove to be effective against cancer stem cells, that today are considered the most “malignant” culprit of cancer.

Francesca Noceti | alfa
Further information:
http://www.ifom-ieo-campus.it
http://www.semm.it/meeting/cancer06/

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>